These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 28674291)
1. [Comprehensive Analyses of Molecules with Altered Expression in the Brain of a Mouse Model of Down Syndrome for Identification of Pharmacotherapeutic Targets]. Ishihara K Yakugaku Zasshi; 2017; 137(7):807-810. PubMed ID: 28674291 [TBL] [Abstract][Full Text] [Related]
2. Absence of Prenatal Forebrain Defects in the Dp(16)1Yey/+ Mouse Model of Down Syndrome. Goodliffe JW; Olmos-Serrano JL; Aziz NM; Pennings JL; Guedj F; Bianchi DW; Haydar TF J Neurosci; 2016 Mar; 36(10):2926-44. PubMed ID: 26961948 [TBL] [Abstract][Full Text] [Related]
3. On the cause of mental retardation in Down syndrome: extrapolation from full and segmental trisomy 16 mouse models. Galdzicki Z; Siarey R; Pearce R; Stoll J; Rapoport SI Brain Res Brain Res Rev; 2001 Apr; 35(2):115-45. PubMed ID: 11336779 [TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans. De la Torre R; De Sola S; Pons M; Duchon A; de Lagran MM; Farré M; Fitó M; Benejam B; Langohr K; Rodriguez J; Pujadas M; Bizot JC; Cuenca A; Janel N; Catuara S; Covas MI; Blehaut H; Herault Y; Delabar JM; Dierssen M Mol Nutr Food Res; 2014 Feb; 58(2):278-88. PubMed ID: 24039182 [TBL] [Abstract][Full Text] [Related]
5. Segmental trisomy of chromosome 17: a mouse model of human aneuploidy syndromes. Vacík T; Ort M; Gregorová S; Strnad P; Blatny R; Conte N; Bradley A; Bures J; Forejt J Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4500-5. PubMed ID: 15755806 [TBL] [Abstract][Full Text] [Related]
6. Mouse models of cognitive disabilities in trisomy 21 (Down syndrome). Roubertoux PL; Carlier M Am J Med Genet C Semin Med Genet; 2010 Nov; 154C(4):400-16. PubMed ID: 20981769 [TBL] [Abstract][Full Text] [Related]
7. Effect of DYRK1A activity inhibition on development of neuronal progenitors isolated from Ts65Dn mice. Mazur-Kolecka B; Golabek A; Kida E; Rabe A; Hwang YW; Adayev T; Wegiel J; Flory M; Kaczmarski W; Marchi E; Frackowiak J J Neurosci Res; 2012 May; 90(5):999-1010. PubMed ID: 22252917 [TBL] [Abstract][Full Text] [Related]
8. [Identification of molecules with altered expression in the brain of mouse model for Down syndrome by comprehensive analyses]. Ishihara K Yakugaku Zasshi; 2013; 133(9):989-94. PubMed ID: 23995807 [TBL] [Abstract][Full Text] [Related]
9. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome. Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K Hum Mol Genet; 2004 Jul; 13(13):1333-40. PubMed ID: 15138197 [TBL] [Abstract][Full Text] [Related]
10. Ts1Cje Down syndrome model mice exhibit environmental stimuli-triggered locomotor hyperactivity and sociability concurrent with increased flux through central dopamine and serotonin metabolism. Shimohata A; Ishihara K; Hattori S; Miyamoto H; Morishita H; Ornthanalai G; Raveau M; Ebrahim AS; Amano K; Yamada K; Sago H; Akiba S; Mataga N; Murphy NP; Miyakawa T; Yamakawa K Exp Neurol; 2017 Jul; 293():1-12. PubMed ID: 28336394 [TBL] [Abstract][Full Text] [Related]
11. Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model. Guidi S; Stagni F; Bianchi P; Ciani E; Giacomini A; De Franceschi M; Moldrich R; Kurniawan N; Mardon K; Giuliani A; Calzà L; Bartesaghi R Brain; 2014 Feb; 137(Pt 2):380-401. PubMed ID: 24334313 [TBL] [Abstract][Full Text] [Related]
12. Molecular and cellular mechanisms elucidating neurocognitive basis of functional impairments associated with intellectual disability in Down syndrome. Rachidi M; Lopes C Am J Intellect Dev Disabil; 2010 Mar; 115(2):83-112. PubMed ID: 20441388 [TBL] [Abstract][Full Text] [Related]
13. Vasoactive intestinal peptide in the brain of a mouse model for Down syndrome. Hill JM; Ades AM; McCune SK; Sahir N; Moody EM; Abebe DT; Crnic LS; Brenneman DE Exp Neurol; 2003 Sep; 183(1):56-65. PubMed ID: 12957488 [TBL] [Abstract][Full Text] [Related]
14. Synaptic pathology of Down syndrome. Garner CC; Wetmore DZ Adv Exp Med Biol; 2012; 970():451-68. PubMed ID: 22351068 [TBL] [Abstract][Full Text] [Related]
15. Enlarged brain ventricles and impaired neurogenesis in the Ts1Cje and Ts2Cje mouse models of Down syndrome. Ishihara K; Amano K; Takaki E; Shimohata A; Sago H; Epstein CJ; Yamakawa K Cereb Cortex; 2010 May; 20(5):1131-43. PubMed ID: 19710359 [TBL] [Abstract][Full Text] [Related]
16. Brain ventriculomegaly in Down syndrome mice is caused by Pcp4 dose-dependent cilia dysfunction. Raveau M; Nakahari T; Asada S; Ishihara K; Amano K; Shimohata A; Sago H; Yamakawa K Hum Mol Genet; 2017 Mar; 26(5):923-931. PubMed ID: 28069794 [TBL] [Abstract][Full Text] [Related]
17. Towards the understanding of Down syndrome using mouse models. Yamakawa K Congenit Anom (Kyoto); 2012 Jun; 52(2):67-71. PubMed ID: 22639990 [TBL] [Abstract][Full Text] [Related]
18. Alterations of brain circuits in Down syndrome murine models. Gotti S; Caricati E; Panzica G J Chem Neuroanat; 2011 Dec; 42(4):317-26. PubMed ID: 21946025 [TBL] [Abstract][Full Text] [Related]
20. Genes Associated with Disturbed Cerebral Neurogenesis in the Embryonic Brain of Mouse Models of Down Syndrome. Ishihara K Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34680993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]